The escalating trade war led by U.S. President Donald Trump is spreading fresh waves of uncertainty across global industries, prompting companies to hike prices, revise earnings forecasts downward, and grapple with volatile supply chains. The fallout is being felt from consumer goods to airlines, as concerns mount over broader economic stability.
On Thursday, corporate earnings reports painted a bleak picture of the first quarter of 2025. Multinational executives are navigating a rapidly shifting landscape driven by the Trump administration’s unpredictable trade policies—policies that many say are complicating decision-making and eroding consumer and investor confidence.
Big Names Cut Outlooks as Costs Rise
Several major firms, including Procter & Gamble, PepsiCo, Thermo Fisher Scientific, and American Airlines, issued warnings or reduced their full-year profit guidance, citing the mounting cost burden from the tariffs. Procter & Gamble’s CFO, Andre Schulten, said the consumer goods giant would deploy “every lever” to absorb the increased costs into its operations, including raising prices.
“Making knee-jerk changes to sourcing or production doesn’t make sense when decisions take months or even years to implement or reverse,” Schulten noted.
Consumers Pull Back as Confidence Wanes
The impact is being felt in consumer behavior as well. Chipotle Mexican Grill and tissue giant Essity reported that Americans are dining out less, while CEOs of Nestle and Unilever flagged weakening U.S. consumer confidence. PepsiCo’s CFO, Jamie Caulfield, echoed these concerns: “Compared to three months ago, we’re not feeling as positive about the consumer outlook.”
In the past two weeks alone, nearly 30 global firms have either slashed or withdrawn earnings forecasts, according to a Reuters analysis. That list includes building materials company Masco and major U.S. airlines Delta and Southwest.
Tesla has said it will revisit its growth targets in three months, citing the uncertain trade environment and consumer backlash affecting sales of its electric vehicles.
Tariff Tensions Fuel Market Turbulence
In early April, Trump unveiled sweeping tariffs on a range of countries in a highly publicized event. The move sparked market selloffs and shook confidence among investors and consumers alike.
While Trump has since walked back some of the levies, he has simultaneously floated the idea of new, sector-specific tariffs targeting trucking, pharmaceuticals, and semiconductors. Though administration officials point to ongoing international negotiations as signs of progress, businesses say the mixed messages make long-term planning almost impossible.
As a temporary measure, most new tariffs have been paused until July 8. However, a blanket 10% rate remains in place, along with significant duties on imports of aluminum, steel, automobiles, and a staggering 145% tariff on Chinese goods.
Despite hints from Washington that it may ease tariffs on Chinese imports, Beijing has held firm—demanding a full rollback of tariffs before resuming talks.
Markets Wobble but Show Signs of Stabilization
The U.S. stock market has shown modest recovery this week, buoyed by suggestions that the White House may soften some trade measures. Stocks rose Thursday, extending a midweek rally, though the S&P 500 remains down 7.5% year-to-date.
Companies Shift Strategy, Investments
South Korea’s Hyundai Motor has responded by relocating some production of its Tucson SUVs from Mexico to the U.S. The company said it expects the challenging business climate to persist, citing “intensifying trade wars and unpredictable macroeconomic factors.” Hyundai and its affiliate Kia—which together form the world’s third-largest automaker—derive about a third of their sales from the U.S. market, with imports accounting for around two-thirds of their U.S. sales.
Hyundai is also weighing additional production shifts from South Korea to other regions in response to the ongoing trade pressures.
Elsewhere, several pharmaceutical giants are reaffirming or expanding U.S. investment despite concerns over proposed healthcare spending cuts and layoffs at the FDA. Bristol Myers CFO David Elkins stressed the importance of protecting medical innovation and ensuring access to vital treatments.
China Responds with Domestic Focus
In China, the government and private sector are ramping up efforts to redirect export-focused companies toward the domestic market. E-commerce giant JD.com reported that nearly 3,000 companies have expressed interest in a new 200 billion yuan ($27.35 billion) fund it launched earlier this month to support this transition.
